Erratum: NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy

Vicente Rodrigues Marczyk(The University of Texas MD Anderson Cancer Center), Maria E. Cabanillas(The University of Texas MD Anderson Cancer Center), Keyur P. Patel(The University of Texas MD Anderson Cancer Center), Mark Zafereo(Texas Medical Center), Sinchita Roy‐Chowdhuri(The University of Texas MD Anderson Cancer Center), David S. Hong(The University of Texas MD Anderson Cancer Center), Sasan Fazeli(The University of Texas MD Anderson Cancer Center), Steven G. Waguespack(The University of Texas MD Anderson Cancer Center), Mark J. Routbort(The University of Texas MD Anderson Cancer Center), Naifa L. Busaidy(The University of Texas MD Anderson Cancer Center), Jennifer Wang(The University of Texas MD Anderson Cancer Center), Anastasios Maniakas(The University of Texas MD Anderson Cancer Center), Michelle D. Williams(The University of Texas MD Anderson Cancer Center), S. Mohsen Hosseini(University of Toronto), Ramona Dadu(The University of Texas MD Anderson Cancer Center), Mimi I. Hu(The University of Texas MD Anderson Cancer Center), Steven I. Sherman(Johns Hopkins University), Salmaan Ahmed(The University of Texas MD Anderson Cancer Center), Sarah Hamidi(The University of Texas MD Anderson Cancer Center), F. Anthony San Lucas(The University of Texas MD Anderson Cancer Center), Priyanka Iyer(The University of Texas MD Anderson Cancer Center)
JCO Precision Oncology
July 1, 2025
Cited by 4


Related Papers